Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00346528 · ClinicalTrials.gov registry record · Phase 3
Safety of NGOIS Compared to BSS Plus in Pediatric Patients
A Phase 3 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 18
- Enrollment target
NCT00346528 is a Phase 3 study that has completed, run by Alcon Research. The registered enrollment target is 18 participants.
The verdict
NCT00346528, a Phase 3 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 18 participants
- Enrollment target
Study Summary
To evaluate the Safety of Next Generation Ophthalmic Irrigating Solution compared to BSS Plus for use during cataract surgery in Pediatric patients.
Interventions
- DRUG BSS Plus
- DRUG Next Generation Ophthalmic Irrigating Solution (NGOIS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2006-07 |
| Est. Completion | 2007-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00346528
The ClinicalTrials.gov registry entry for NCT00346528 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BSS Plus is the first listed.
NCT00346528 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00346528 about?
NCT00346528 is a clinical study titled "Safety of NGOIS Compared to BSS Plus in Pediatric Patients". To evaluate the Safety of Next Generation Ophthalmic Irrigating Solution compared to BSS Plus for use during cataract surgery in Pediatric patients.
What is the current status of trial NCT00346528?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 18 participants. The study started on 2006-07. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00346528?
The interventions under investigation include: BSS Plus (DRUG), Next Generation Ophthalmic Irrigating Solution (NGOIS) (DRUG).
Who is sponsoring clinical trial NCT00346528?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.